Phase I Trial of CCI-779 (Temsirolimus) and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma.

被引：0

作者：

Ghobrial, Irene M. ^{[1
]}

Munshi, Nikhil ^{[1
]}

Schlossman, Robert ^{[1
]}

Chuma, Stacey ^{[1
]}

Leduc, Renee ^{[1
]}

Nelson, Marybeth ^{[1
]}

Sam, Amy ^{[1
]}

O'Connor, Kelly ^{[1
]}

Harris, Brianna ^{[1
]}

Warren, Diane ^{[1
]}

Dollard, Akari M. ^{[2
]}

Laubach, Jacob ^{[1
]}

Vij, Ravi ^{[3
]}

Campagnaro, Erica ^{[4
]}

Birner, Ann ^{[5
]}

Dixon-Lipscomb, Virginia

Anderson, Kenneth C. ^{[1
]}

Richardson, Paul G. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] MMRC, Norwalk, CT USA

[3] Washington Univ, St Louis, MO USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] Millennium Pharmaceut Inc, Cambridge, MA USA

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1266 / 1266

页数：1

共 50 条

[41] A phase II study of elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.
Yee, Andrew Jenho
Laubach, Jacob
Campagnaro, Erica Leigh
Lipe, Brea
Nadeem, Omar
Cole, Craig
O'Donnell, Elizabeth
Schlossman, Robert L.
Bianchi, Giada
Branagan, Andrew Robert
Shapiro, Samantha J.
Harrington, Cynthia C.
Burke, Jill N.
Gammon, Marilyn T.
Lively, Kathleen J.
Thorburn, Cassandra Ann
Mann, Mason L.
Lohr, Jens Guenter
Richardson, Paul G.
Raje, Noopur S.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[42] A phase I/II trial of bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma.
Popat, Rakesh
Williams, Catherine
Cook, Mark
Craddock, Charles
Basu, Supratik
Singer, Charles
Odeh, Liz
Foot, Nicola
Oakervee, Heather
Cavenagh, James D.
BLOOD, 2006, 108 (11) : 1011A - 1011A
[43] Phase lb study of panobinostat in combination with lenalidomide, bortezomib, and dexamethasone in relapsed refractory multiple myeloma.
Laubach, Jacob
Tuchman, Sascha Alexander
Rosenblatt, Jacalyn
Redd, Robert
Colson, Kathleen
Motta, Ashley
Fitzpatrick, Kathleen
Weller, Edie
Richardson, Paul G.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[44] A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors
Fujisaka, Yasuhito
Yamada, Yasuhide
Yamamoto, Noboru
Horiike, Atsushi
Tamura, Tomohide
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (08) : 732 - 738
[45] A Phase I MMRC Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma
Lonial, Sagar
Francis, Dixil
Karanes, Chatchada
Trudel, Suzanne
Reece, Donna E.
Krishnan, Amrita
Buacharem, Marc
Smith, Renee
Zaman, Faraz
Gul, Engin
Dollard, Akari M.
Harvey, Donald
Kaufman, Jonathan
BLOOD, 2008, 112 (11) : 1270 - 1270
[46] A phase I MMRC clinical trial testing the combination of bortezomib and tipifarnib in relapsed/refractory multiple myeloma
Lonial, S.
Francis, D.
Karanes, C.
Trudel, S.
Dollard, A.
Harvey, D.
Kaufman, J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[47] Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
Badros, Ashraf
Burger, Angelika M.
Philip, Sunita
Niesvizky, Ruben
Kolla, Sarah S.
Goloubeva, Olga
Harris, Carolynn
Zwiebel, James
Wright, John J.
Espinoza-Delgado, Igor
Baer, Maria R.
Holleran, Julianne L.
Egorin, Merrill J.
Grant, Steven
CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5250 - 5257
[48] Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
Richardson, Paul G.
Weller, Edie
Jagannath, Sundar
Avigan, David E.
Alsina, Melissa
Schlossman, Robert L.
Mazumder, Amitabha
Munshi, Nikhil C.
Ghobrial, Irene M.
Doss, Deborah
Warren, Diane L.
Lunde, Laura E.
McKenney, Mary
Delaney, Carol
Mitsiades, Constantine S.
Hideshima, Teru
Dalton, William
Knight, Robert
Esseltine, Dixie-Lee
Anderson, Kenneth C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5713 - 5719
[49] A phase II study of daratumumab with weekly carfilzomib, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma.
Yee, Andrew J.
Nadeem, Omar
Rosenblatt, Jacalyn
Bianchi, Giada
O'Donnell, Elizabeth
Branagan, Andrew R.
Harrington, Cynthia C.
Agyemang, Emerentia A.
Gammon, Marilyn T.
Lively, Kathleen J.
Packer, Lisette A.
Bernstein, Zachary S.
Lyons, Rebecca T.
Riadi, Manal
Rowell, Sean M.
Mcvey, Cailin
Goguen, Amy C.
Horick, Nora K.
Richardson, Paul G.
Raje, Noopur S.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[50] Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779
Shi, YJ
Gera, J
Hu, LP
Hsu, JH
Bookstein, R
Li, WQ
Lichtenstein, A
CANCER RESEARCH, 2002, 62 (17) : 5027 - 5034

← 1 2 3 4 5 →